Tan et al. study has shown that hepcidin/ferritin ratio, is lower in cirrhotic than non-cirrhotic patients with HBV, HCV and NAFLD (Sun et al. 2015). The gene discussed is HAMP; the disease is metabolic dysfunction-associated steatotic liver disease.